These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 19031945

  • 1. Expression and prognostic significance of PDCD4 in human epithelial ovarian carcinoma.
    Wang X, Wei Z, Gao F, Zhang X, Zhou C, Zhu F, Wang Q, Gao Q, Ma C, Sun W, Kong B, Zhang L.
    Anticancer Res; 2008; 28(5B):2991-6. PubMed ID: 19031945
    [Abstract] [Full Text] [Related]

  • 2. Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis.
    Chen Y, Knösel T, Kristiansen G, Pietas A, Garber ME, Matsuhashi S, Ozaki I, Petersen I.
    J Pathol; 2003 Aug; 200(5):640-6. PubMed ID: 12898601
    [Abstract] [Full Text] [Related]

  • 3. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
    Shigemasa K, Tian X, Gu L, Tanimoto H, Underwood LJ, O'Brien TJ, Ohama K.
    Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549
    [Abstract] [Full Text] [Related]

  • 4. Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer.
    Kusuda T, Shigemasa K, Arihiro K, Fujii T, Nagai N, Ohama K.
    Oncol Rep; 2005 Jun; 13(6):1153-8. PubMed ID: 15870936
    [Abstract] [Full Text] [Related]

  • 5. Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression.
    Lu L, Katsaros D, Wiley A, de la Longrais IA, Puopolo M, Yu H.
    Cancer Invest; 2008 Mar; 26(2):185-92. PubMed ID: 18259951
    [Abstract] [Full Text] [Related]

  • 6. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer.
    Mudduluru G, Medved F, Grobholz R, Jost C, Gruber A, Leupold JH, Post S, Jansen A, Colburn NH, Allgayer H.
    Cancer; 2007 Oct 15; 110(8):1697-707. PubMed ID: 17849461
    [Abstract] [Full Text] [Related]

  • 7. Frequent loss of PDCD4 expression in human glioma: possible role in the tumorigenesis of glioma.
    Gao F, Zhang P, Zhou C, Li J, Wang Q, Zhu F, Ma C, Sun W, Zhang L.
    Oncol Rep; 2007 Jan 15; 17(1):123-8. PubMed ID: 17143488
    [Abstract] [Full Text] [Related]

  • 8. Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy.
    Bignotti E, Tassi RA, Calza S, Ravaggi A, Romani C, Rossi E, Falchetti M, Odicino FE, Pecorelli S, Santin AD.
    Gynecol Oncol; 2006 Nov 15; 103(2):405-16. PubMed ID: 16725184
    [Abstract] [Full Text] [Related]

  • 9. [Human pituitary tumor transforming gene 1 expression in ovarian carcinoma and its clinical significance].
    Cheng YX, Feng J, Zhang XY, Fu TY, Yao Y.
    Ai Zheng; 2004 Sep 15; 23(9):1026-30. PubMed ID: 15363195
    [Abstract] [Full Text] [Related]

  • 10. Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients.
    Bignotti E, Todeschini P, Calza S, Falchetti M, Ravanini M, Tassi RA, Ravaggi A, Bandiera E, Romani C, Zanotti L, Tognon G, Odicino FE, Facchetti F, Pecorelli S, Santin AD.
    Eur J Cancer; 2010 Mar 15; 46(5):944-53. PubMed ID: 20060709
    [Abstract] [Full Text] [Related]

  • 11. [Expression of programmed cell death 4 and its clinicopathological significance in human pancreatic cancer].
    Ma G, Guo KJ, Zhang H, Ozaki I, Matsuhashi S, Zheng XY, Dong M.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct 15; 27(5):597-600. PubMed ID: 16274040
    [Abstract] [Full Text] [Related]

  • 12. Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas.
    Yakirevich E, Sabo E, Naroditsky I, Sova Y, Lavie O, Resnick MB.
    Gynecol Oncol; 2006 Jan 15; 100(1):152-9. PubMed ID: 16198399
    [Abstract] [Full Text] [Related]

  • 13. [Correlation of DPPIV expression with clinicopathological features and prognosis in epithelial ovarian carcinoma].
    Zhang MZ, Qiao YH, Suo ZH.
    Zhonghua Zhong Liu Za Zhi; 2008 Nov 15; 30(11):848-52. PubMed ID: 19173831
    [Abstract] [Full Text] [Related]

  • 14. [The relation of peroxisome proliferator activated receptorbeta and Epithelial Ovarian Carcinoma].
    Yang Y, Hou JQ, Ju HW, Yu ZH, Zhao ZW, Yang S, Yang HJ.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jul 15; 23(7):630-2. PubMed ID: 17618585
    [Abstract] [Full Text] [Related]

  • 15. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker.
    Yousef GM, Kyriakopoulou LG, Scorilas A, Fracchioli S, Ghiringhello B, Zarghooni M, Chang A, Diamandis M, Giardina G, Hartwick WJ, Richiardi G, Massobrio M, Diamandis EP, Katsaros D.
    Cancer Res; 2001 Nov 01; 61(21):7811-8. PubMed ID: 11691797
    [Abstract] [Full Text] [Related]

  • 16. Fascin expression in serous tumors of ovary correlates with aggressiveness of malignancy.
    Wen YH, Yee H, Goswami S, Shukla PS.
    Int J Gynecol Pathol; 2009 Mar 01; 28(2):187-92. PubMed ID: 19188814
    [Abstract] [Full Text] [Related]

  • 17. The potential prognostic value of cathepsin D protein in serous ovarian cancer.
    Chai Y, Wu W, Zhou C, Zhou J.
    Arch Gynecol Obstet; 2012 Aug 01; 286(2):465-71. PubMed ID: 22476353
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of beta1-integrin (=CD29) in serous adenocarcinomas of the ovary.
    Müller-Klingspor V, Hefler L, Obermair A, Kaider A, Breitenecker G, Leodolte S, Kohlberger P.
    Anticancer Res; 2001 Aug 01; 21(3C):2185-8. PubMed ID: 11501844
    [Abstract] [Full Text] [Related]

  • 19. Clinicopathological significance of DEK overexpression in serous ovarian tumors.
    Han S, Xuan Y, Liu S, Zhang M, Jin D, Jin R, Lin Z.
    Pathol Int; 2009 Jul 01; 59(7):443-7. PubMed ID: 19563407
    [Abstract] [Full Text] [Related]

  • 20. DNA fragmentation factor (DFF45): expression and prognostic value in serous ovarian cancer.
    Brustmann H.
    Pathol Res Pract; 2006 Jul 01; 202(10):713-20. PubMed ID: 16962250
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.